For citations:
Galankin N.A., Tadtaeva Z.G., Sardaryan I.S., Galustyan A.N., Gromova O.A. Impact of CYP2C9, CYP2C19 and ABCB1 genetic polymorphisms on antiepileptic drug safety and efficacy. Epilepsy and paroxysmal conditions. 2025;17(1):70-81. (In Russ.) https://doi.org/10.17749/2077-8333/epi.par.con.2025.240
Views PDF (Rus): 29
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Email this article 
